139 related articles for article (PubMed ID: 5510366)
1. Effects of hexobendine on cardiac metabolism and blood supply.
Raberger G; Kraupp O
Brux Med; 1970 Sep; 50(9):645-50. PubMed ID: 5510366
[No Abstract] [Full Text] [Related]
2. [Animal experiment study on the coronary and circulatory effect of dipyridamole, carbocromen, hexobendine, dilazep and glucagon].
Reploh HD
Arzneimittelforschung; 1973 May; 23(5):629-39. PubMed ID: 4740201
[No Abstract] [Full Text] [Related]
3. Studies with coronary-active drugs.
Haas H
Brux Med; 1970 Sep; 50(9):665-8. PubMed ID: 5510369
[No Abstract] [Full Text] [Related]
4. The cardiovascular pharmacology of lidoflazine.
Schaper W; Jageneau A; Xhonneux R
Brux Med; 1970 Sep; 50(9):635-8. PubMed ID: 5510364
[No Abstract] [Full Text] [Related]
5. [Epontol and coronary circulation].
Garcia Betancourt L
Anaesthesist; 1970 Jan; 19(1):48-51. PubMed ID: 5440158
[No Abstract] [Full Text] [Related]
6. [Effect of 1,4-bis(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine dihydrochloride on cardiac metabolism, hemodynamics and coronary and renal blood flow].
Hensel I; Bretschneider HJ; Kettler D; Knoll D; Kochsiek K; Reploh HD; Spieckermann PG; Tauchert M
Arzneimittelforschung; 1972 Apr; 22(4):652-63. PubMed ID: 5068243
[No Abstract] [Full Text] [Related]
7. [Effects of flavon-7-ethyl oxyacetate on the cardiovascular system].
Takenaka F; Takeya N; Tazume Y; Hayakawa T; Sakai M
Kumamoto Igakkai Zasshi; 1967 Sep; 41(9):843-8. PubMed ID: 5631463
[No Abstract] [Full Text] [Related]
8. [Pharmacologic bases of antiangina properties of amiodarone].
Charlier R
Brux Med; 1970 Sep; 50(9):651-6. PubMed ID: 5510367
[No Abstract] [Full Text] [Related]
9. [On the necessity to resume and enlarge pharmacologic and clinical studies of a molecule during the advancement of its therapeutic utilization: pharmacology of trimetazidine].
Vigne J
Brux Med; 1970 Sep; 50(9):601-8. PubMed ID: 5510360
[No Abstract] [Full Text] [Related]
10. Some effects of iproveratril (Isoptin) on the cardiovascular system.
Nayler WG; McInnes I; Swann JB; Price JM; Carson V; Race D; Lowe TE
J Pharmacol Exp Ther; 1968 Jun; 161(2):247-61. PubMed ID: 5650138
[No Abstract] [Full Text] [Related]
11. [Influencing of oxygen pressure in the myocardium by coronary dilators].
Kadatz R; Diederen W
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):156-9. PubMed ID: 5804228
[No Abstract] [Full Text] [Related]
12. [Effect of hexobendine on the arterial and coronary venous CO2 tension and hydrogen-ion concentration in dogs. Contribution on the theory of the mechanism of action of coronary dilator agents].
Kraupp O; Grossmann W; Stühlinger W; Raberger G
Arzneimittelforschung; 1968 Aug; 18(8):1067-73. PubMed ID: 5755840
[No Abstract] [Full Text] [Related]
13. [Effect of dilating agents on collateral coronary circulation and oxygen tension in the myocardium].
Sapozhikov AV
Farmakol Toksikol; 1968; 31(6):687-90. PubMed ID: 5713578
[No Abstract] [Full Text] [Related]
14. Regional blood flow and cardiac responses to hydralazine.
Spokas EG; Wang HH
J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
[No Abstract] [Full Text] [Related]
15. [Enhancement of the coronary dilator action of i.v. and i.c. administered adenosine following intraduodenal provision of hexobendine in dogs].
Raberger G; Kraupp O
Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):430-1. PubMed ID: 4254341
[No Abstract] [Full Text] [Related]
16. [The effect of nitranol, nitropenton and nitrosorbid on the rate of the coronary blood flow and on the oxygen consumption of the myocardium].
Buianov VV
Farmakol Toksikol; 1967; 30(1):30-4. PubMed ID: 5594355
[No Abstract] [Full Text] [Related]
17. [On the mechanism of action of coronary dilators].
Kraupp O
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):144-55. PubMed ID: 5804227
[No Abstract] [Full Text] [Related]
18. [Selective influencing of the myocardial blood supply in dogs using drugs].
Hapke HJ
Dtsch Tierarztl Wochenschr (1946); 1969 Oct; 76(19):518-21. PubMed ID: 5355903
[No Abstract] [Full Text] [Related]
19. The effects of a new drug (hexobendine) on cerebral hemodynamics and oxygen consumption.
Meyer JS; Kondo A; Szewczykowski J; Nomura F; Teraura T
J Neurol Sci; 1970 Aug; 11(2):137-45. PubMed ID: 4989597
[No Abstract] [Full Text] [Related]
20. [Effect of hexabendin on oxygen consumption, energetics and substrate metabolism of the heart. II. Studies with intravenously administered single doses].
Kraupp O; Wolner E; Adler-Kastner L; Chirikdjian JJ; Ploszczanski B; Tuisl E
Arzneimittelforschung; 1966 Jun; 16(6):692-7. PubMed ID: 6014577
[No Abstract] [Full Text] [Related]
[Next] [New Search]
